Treace Medical Concepts, Inc. Inventory Write-down
Treace Medical Concepts, Inc. (TMCI) reported Inventory Write-down of $0 for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2023-11-09
- Treace Medical Concepts, Inc. inventory write-down for the quarter ending 2023-09-30 was $0.00.
- Treace Medical Concepts, Inc. inventory write-down for the quarter ending 2022-09-30 was -$9.00K, a 109.89% decline year-over-year.
- Treace Medical Concepts, Inc. inventory write-down for the quarter ending 2022-06-30 was -$194.00K, a 268.70% decline year-over-year.
- Treace Medical Concepts, Inc. inventory write-down for the quarter ending 2022-03-31 was -$3.00K.
- Treace Medical Concepts, Inc. inventory write-down for fiscal 2021 was $347.00K, a 69.67% decline from fiscal 2020.
- Treace Medical Concepts, Inc. inventory write-down for fiscal 2020 was $1.14M.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-09 | |||
| 2022-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$203.00K derived: sum of 2 quarters · filed 2023-11-09 | -$206.00K 10-Q · filed 2023-11-09 | -$38.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$194.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$197.00K 10-Q · filed 2023-08-09 | -$29.00K derived: sum of 3 quarters · filed 2023-08-09 | $62.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$3.00K 10-Q · filed 2022-05-06 | $165.00K derived: sum of 2 quarters · filed 2022-05-06 | $256.00K derived: sum of 3 quarters · filed 2022-11-09 | $371.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-12-31 | $168.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $259.00K derived: sum of 2 quarters · filed 2022-11-09 | $374.00K derived: sum of 3 quarters · filed 2022-11-09 | $347.00K 10-K · filed 2022-03-04 |
| 2021-09-30 | $91.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $206.00K derived: sum of 2 quarters · filed 2022-11-09 | $179.00K 10-Q · filed 2022-11-09 | $795.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $115.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $88.00K 10-Q · filed 2022-08-10 | $704.00K derived: sum of 3 quarters · filed 2022-08-10 | $820.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | -$27.00K 10-Q · filed 2022-05-06 | $589.00K derived: sum of 2 quarters · filed 2022-05-06 | $705.00K derived: sum of 3 quarters · filed 2022-05-06 | $1.06M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $616.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $732.00K derived: sum of 2 quarters · filed 2022-03-04 | $1.09M derived: sum of 3 quarters · filed 2022-03-04 | $1.14M 10-K · filed 2022-03-04 |
| 2020-09-30 | $116.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $475.00K derived: sum of 2 quarters · filed 2021-11-04 | $528.00K 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $359.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $412.00K 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $53.00K 10-Q · filed 2021-05-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |